PBMs say Big Pharma is responsible for high drug prices, Alexa has new HIPAA-compliant skills, D-SNP look-alike plans may soon be at risk, and more industry news from the past week.
In this Q&A, Chris Cornelison, Pharm.D, owner of Iuka Discount Drugs and Solutions Rx sheds light on his pharmacy’s experiences with OTC products.
The FDA wants to hear your experiences with CBD, the telemedicine market is on the rise, and more healthcare and pharmacy news to know this week.
Welcome to the first edition of Amplicare’s weekly news roundup. Each week, we’ll share five news stories to keep you up-to-date on what’s happening in the healthcare and pharmaceutical industries. Look for us every Friday afternoon.
With the opioid epidemic reaching monumental heights, pharmacists must continue to help communities understand the benefits of medication like naloxone.
Amplicare and Ananda Professional are excited to announce a partnership to expand pharmacy access to CBD and wellness education through automation software.
The updates are specifically aimed at addressing the opioid epidemic and the effects of flu season.
Armed with the right tools and information, pharmacists play an integral role in ensuring that communities understand the importance of the flu vaccination.
Beginning in 2019, there will be a new Open Enrollment Period for Medicare Advantage. This period will run from January 1 – March 31. If any of your patients are enrolled in a Medicare Advantage plan, they have a one-time opportunity during this period to…
Amplicare Assist is the go-to solution for pharmacists looking to shed dashboards without sacrificing productivity, profit, or quality of care.